75 HAYDEN AVENUE, LEXINGTON, MA
Market cap: $222.4M (12/18/2025)
Price: $4.00
Reports Third Quarter 2025 Financial and Operating Results
Leveraging Genetics to Treat Neurological Diseases 2025 Biopharma Back to School Conference September 2, 2025
Earnings Release
News
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
Other Events
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Confidential Treatment Order
SEC Staff Correspondence